Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Mauro Braun, MD, is a staff member of the Department of Nephrology / Hypertension at Cleveland Clinic Florida, where he serves as Program Director of the Nephrology Fellowship Program. His specialty interests include dialysis (acute and chronic), renal replacement therapies, lupus nephritis and glomerular diseases. He is certified by the American Board of Internal Medicine, with a subspecialty in nephrology.
He received his medical degree from Federal University of Rio de Janeiro, School of Medicine, Rio de Janeiro, Brazil in 1979. He completed his internal medical internship at University Hospital, Federal University of Rio de Janeiro in Rio de Janeiro, Brazil and he completed his internal medicine/nephrology residency at State University of Rio de Janeiro, Pedro Ernesto University Hospital, Rio de Janeiro, Brazil. He completed his internal medicine internship and residency and nephrology fellowship at University of New Mexico, Albuquerque, NM.
Dr. Braun was a clinical staff member in the Nephrology Division, Department of Medicine, Andarai Hospital, National Institute of Medical Assistance and Social Previdence in Rio de Janeiro, Brazil from 1982-1993. He was also a clinical staff member of the Nephrology Unit of Albert Sabin Jewish Hospital in Rio de Janeiro, Brazil from 1984-1993. He was a nephrologist at Army Central Hospital in Rio de Janeiro, Brazil from 1984-1986 and also at Central Hospital of the Rio de Janeiro State Workers Institute of Assistance in Rio de Janeiro, Brazil, from 1987-1989. Later, he served as a internist/nephrologist at Kirkpatrick Family Care in Longview, Wash., from 1999-2002. In addition he was Assistant Professor, Division of Nephrology/Hypertension at Oregon Health & Science University in Portland, Ore., from 2002-2003.
He belongs to various professional societies, including the International Society of Nephrology, American Society of Nephrology, Florida Society of Nephrology and the National Kidney Foundation.
chronic kidney disease, dialysis, chronic kidney disease, dialysis and kidney biopsy, end stage renal disease, general nephrology, glomerulonephritis, hypertension, renal biopsies, renal transplantation medicine
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/30/2012, Dr. Braun has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.